Tower Research Capital (TRC)’s SeaStar Medical ICU Stock Holding History
Bought
Maintained
Sold
Other funds holding ICU
Tower Research Capital (TRC)'s ICU Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its SeaStar Medical (ICU) stake by 58% in Q3 2026, selling an estimated $2.84K and leaving 565 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #5120.
Tower Research Capital (TRC) first reported a position in ICU in Q1 2022 and has held it in 18 quarters since. The position peaked at $10K in Q3 2022. 20 funds tracked by Wall St. Rank hold ICU as of Q3 2026.
- Tower Research Capital (TRC) held 565 shares of SeaStar Medical worth $2.23K as of Q3 2026.
- Tower Research Capital (TRC) sold 791 SeaStar Medical shares in Q3 2026, an estimated $2.84K.
- SeaStar Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5120 holding.
- Tower Research Capital (TRC) first reported a position in SeaStar Medical in Q1 2022 and has held it in 18 quarters since.
- Tower Research Capital (TRC)'s SeaStar Medical position peaked at $10K in Q3 2022.
- 20 funds tracked by Wall St. Rank held SeaStar Medical as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.